Stock Events

Stock Events

Marker Therapeutics (MRKR) Q3 2024 Earnings

14AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.43

-0.37

-0.31

-0.25

Details

Expected EPS

-0.4309

Actual EPS

-0.25

Surprise EPS

0.18

Surprise Percent

+41.98%

Description

Marker Therapeutics (MRKR) has reported earnings of -0.25 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.